Aldeyra Therapeutics ALDX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 5.75 | 110.39 | -0.17 | -10,427 | -10 | |
| 2024Q4 | 4.99 | 108.08 | -0.27 | -16,578 | -16 | |
| 2024Q3 | 5.39 | 110.28 | -0.25 | -16,138 | -15 | |
| 2024Q2 | 3.31 | 110.01 | -0.28 | -18,008 | -17 | |
| 2024Q1 | 3.27 | 123.87 | -0.14 | -9,394 | -8 | |
| 2023Q4 | 3.51 | 143.85 | -0.08 | -6,098 | -5 | |
| 2023Q3 | 6.68 | 124.87 | -0.14 | -9,550 | -8 | |
| 2023Q2 | 8.39 | 122.26 | -0.15 | -10,343 | -9 | |
| 2023Q1 | 9.93 | 111.10 | -0.27 | -16,803 | -16 | |
| 2022Q4 | 6.96 | 110.09 | -0.22 | -13,697 | -13 | |
| 2022Q3 | 5.34 | 104.58 | -0.25 | -14,785 | -15 | |
| 2022Q2 | 3.99 | 101.98 | -0.30 | -17,715 | -18 | |
| 2022Q1 | 4.45 | 100.62 | -0.29 | -16,484 | -17 | |
| 2021Q4 | 4.00 | 100.41 | -0.27 | -15,404 | -16 | |
| 2021Q3 | 8.78 | 100.38 | -0.28 | -15,441 | -16 | |
| 2021Q2 | 11.33 | 100.28 | -0.27 | -14,543 | -15 | |
| 2021Q1 | 11.88 | 100.22 | -0.25 | -10,831 | -11 | |
| 2020Q4 | 6.86 | 100.04 | -0.30 | -11,288 | -11 | |
| 2020Q3 | 7.41 | 100.06 | -0.22 | -8,389 | -9 | |
| 2020Q2 | 4.17 | 101.02 | -0.25 | -7,106 | -8 |